According to the study results, the possibility of early PD should be considered if patients with AFP level ≥ 20 ng/mL have an increase in AFP level ≥ 30% at 3 weeks or if patients with AFP level < 20 ng/mL have up-to-seven criteria, OUT, implying high tumor burden. The gene discussed is AFP; the disease is neoplasm.